Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (1.637)

41

CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in the murine model of the acute respiratory distress syndrome

enthalten in: Frontiers in pharmacology | 2024

von Chernov, A. | Rodionov, M. | Kazakov, V. | +6

42

Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients : A retrospective single-center study

enthalten in: SAGE open medicine | 2024

von Ketaroonrut, N. | Kiertiburanakul, S. | Sriphrapradang, C.

43

Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial

in: BMC Complementary Medicine and Therapies | 2024

von Pitchaya Dilokpattanamongkol | Chadakan Yan | Kulapong Jayanama | +3

44

Clinical profile during the first and second pandemic waves in children and adolescents with COVID-19 at pediatric public hospital, Rio de Janeiro, Brazil

in: Microbes, Infection and Chemotherapy | 2024

von Jeferson Tobias da Silva de Oliveira de Oliveira | Luciana Fernandes Portela | Marcelo Carvalho Vieira | +5

45

Assessing medication use patterns by clinical outcomes severity among inpatients with COVID-19: A retrospective drug utilization study

in: Biomedicine & Pharmacotherapy | 2024

von Renato Ferreira-da-Silva | Priscila Maranhão | Cláudia Camila Dias | +5

46

Acute macular neuroretinopathy and COVID-19 or SARS-CoV-2 infection: case report and literature review

in: Frontiers in Medicine | 2024

von Xing Wang | Xing Wang | Peng Wang | +6

47

Case Report of COVID-19 and Pneumocystis coinfection in a pediatric patient with a history of receiving high dose steroid therapy

in: Heliyon | 2024

von Sun Oh Yum | Hwanhee Park | Esther Park

48

IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients

in: BMC Immunology | 2024

von Huan Xie | Jing Zhang | Ran Luo | +5

49

Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster modelResearch in context

in: EBioMedicine | 2024

von Michihito Sasaki | Tatsuki Sugi | Shun Iida | +18

50

Thyroid Stimulating Hormone as a Possible Additional COVID-19 Outcome Marker

in: Medicina | 2024

von Anamarija Zrilic Vrkljan | Ana Majic Tengg | Tanja Palaversa | +4